{"id":9944,"date":"2022-10-11T07:00:00","date_gmt":"2022-10-11T05:00:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022\/"},"modified":"2022-10-11T07:00:00","modified_gmt":"2022-10-11T05:00:00","slug":"irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022\/","title":{"rendered":"IRLAB presenterar bolaget p\u00e5 Redeye Neurology Seminar den 12 oktober 2022"},"content":{"rendered":"

[mfn_before_post]<\/p>\n

\n

G\u00f6teborg, Sverige, 11 oktober 2022 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett biofarmaceutiskt bolag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r de mest besv\u00e4rliga symtomen vid Parkinsons sjukdom, meddelade idag att Richard Godfrey, VD p\u00e5 IRLAB, kommer att presentera bolaget p\u00e5 Redeye Neurology Seminar och delta i en paneldiskussion p\u00e5 onsdag den 12 oktober 2022.<\/strong><\/p>\n<\/div>\n

\n

Bolagets presentation b\u00f6rjar kl. 10:22 och paneldiskussionen kl 10:46 p\u00e5 onsdag den 12 oktober 2022. Eventet s\u00e4nds live via l\u00e4nk p\u00e5 www.redeye.se\/events\/847068\/redeye-theme-neurology#schedule<\/a>, d\u00e4r det \u00e4ven \u00e4r m\u00f6jligt att anm\u00e4la personligt deltagande i lokalen i centrala Stockholm. En inspelning av presentationen kommer att g\u00f6ras tillg\u00e4nglig p\u00e5 bolagets webbplats, www.irlab.se<\/a>, efter eventet.<\/p>\n<\/div>\n

\n

F\u00f6r mer information:<\/strong><\/p>\n

\n

Richard Godfrey, VD
Telefon: +46 730 70 69 00
E-mail:\u00a0richard.godfrey@irlab.se<\/a><\/p>\n<\/div>\n

\n

Om IRLAB<\/strong><\/p>\n

\n

IRLAB uppt\u00e4cker och utvecklar nya l\u00e4kemedel f\u00f6r behandling av Parkinsons sjukdom och andra sjukdomar i hj\u00e4rnan. Bolagets l\u00e4ngst framskridna l\u00e4kemedelskandidater, mesdopetam (IRL790) och pirepemat (IRL752) \u00e4r b\u00e5da i Fas IIb och \u00e4r designade f\u00f6r att behandla n\u00e5gra av de sv\u00e5raste symtomen relaterade till Parkinson. \u00c5r 2021 f\u00f6rv\u00e4rvade Ipsen, ett specialty pharma-bolag, de exklusiva globala r\u00e4ttigheterna till utveckling och kommersialisering av mesdopetam.
\u00a0
IRLAB har genererat alla sina l\u00e4kemedelskandidater och forts\u00e4tter att uppt\u00e4cka innovativa l\u00e4kemedelskandidater f\u00f6r behandling av neurologiska sjukdomar genom den egenutvecklade forskningsplattformen ISP (Integrative Screening Process). F\u00f6rutom IRLAB:s starka kliniska pipeline driver bolaget tv\u00e5 prekliniska program, IRL942 och IRL757, mot Fas I-studier. IRLAB \u00e4r noterat p\u00e5 Nasdaq Stockholm. Mer information p\u00e5\u00a0www.irlab.se.<\/a><\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

IRLAB presenterar bolaget p\u00e5 Redeye Neurology Seminar den 12 oktober 2022<\/a><\/p>\n<\/div>\n

[mfn_after_post]<\/p>\n","protected":false},"excerpt":{"rendered":"

G\u00f6teborg, Sverige, 11 oktober 2022 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett biofarmaceutiskt bolag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r de mest besv\u00e4rliga symtomen vid Parkinsons sjukdom, meddelade idag att Richard Godfrey, VD p\u00e5 IRLAB, kommer att presentera bolaget p\u00e5 Redeye Neurology Seminar och delta i en paneldiskussion p\u00e5 onsdag den 12 oktober 2022.<\/p>\n","protected":false},"template":"","class_list":["post-9944","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ca_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ca-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nIRLAB presenterar bolaget p\u00e5 Redeye Neurology Seminar den 12 oktober 2022 - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB presenterar bolaget p\u00e5 Redeye Neurology Seminar den 12 oktober 2022 - IRLAB\" \/>\n<meta property=\"og:description\" content=\"G\u00f6teborg, Sverige, 11 oktober 2022 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett biofarmaceutiskt bolag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r de mest besv\u00e4rliga symtomen vid Parkinsons sjukdom, meddelade idag att Richard Godfrey, VD p\u00e5 IRLAB, kommer att presentera bolaget p\u00e5 Redeye Neurology Seminar och delta i en paneldiskussion p\u00e5 onsdag den 12 oktober 2022.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022\/\",\"url\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022\/\",\"name\":\"IRLAB presenterar bolaget p\u00e5 Redeye Neurology Seminar den 12 oktober 2022 - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2022-10-11T05:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB presenterar bolaget p\u00e5 Redeye Neurology Seminar den 12 oktober 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB presenterar bolaget p\u00e5 Redeye Neurology Seminar den 12 oktober 2022 - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB presenterar bolaget p\u00e5 Redeye Neurology Seminar den 12 oktober 2022 - IRLAB","og_description":"G\u00f6teborg, Sverige, 11 oktober 2022 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett biofarmaceutiskt bolag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r de mest besv\u00e4rliga symtomen vid Parkinsons sjukdom, meddelade idag att Richard Godfrey, VD p\u00e5 IRLAB, kommer att presentera bolaget p\u00e5 Redeye Neurology Seminar och delta i en paneldiskussion p\u00e5 onsdag den 12 oktober 2022.","og_url":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022\/","url":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022\/","name":"IRLAB presenterar bolaget p\u00e5 Redeye Neurology Seminar den 12 oktober 2022 - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2022-10-11T05:00:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/mfn_news\/irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-bolaget-pa-redeye-neurology-seminar-den-12-oktober-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB presenterar bolaget p\u00e5 Redeye Neurology Seminar den 12 oktober 2022"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/9944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=9944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}